3 Million times 1000 is 3 Billion -
3000 times a Million is 4.8 Billion -
the word BILLION...1 0 0 0 0 0 0 0 0 0 0. -
a very large amount of fiat Money -
is the reason we invest in Gold REAL MONEY -
It comes out of the Moneta ground -
NI 43-101 3.14 MILLION OUNCES AU GROWING
http://www.monetaporcupine.com/s/Home.asp
http://www.monetaporcupine.com/i/pdf/2012-05-23_NR-AGM.pdf
Moneta holds a 100% interest in 5 core gold projects
strategically located along the Destor Porcupine Fault
Zone in the world class Timmins Camp with excellent
infrastructure including access roads, water, electricity,
and mills.
The land position is one of the largest - after three gold
producers - including the highly prospective
Golden Highway Project which covers 12 kilometers of a
volcanic/sedimentary belt along the Destor Porcupine
Fault Zone and hosts a
NI 43-101 indicated resource of
1.07 million ounces gold (33.5 Mt at 1.00 g/t) plus a
NI 43-101 inferred resource of 2.07 million ounces gold
(47.8 Mt at 1.35 g/t) clustered within 4 kilometres.
http://investorshub.advfn.com/Moneta-Porcupine-Mines-Inc-TSE-ME-5495/
Recent ME News
- Potter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach Case • Business Wire • 04/30/2024 03:00:00 PM
- 23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 04/24/2024 08:05:00 PM
- 23andMe announces CEO’s intention to pursue a potential take-private • GlobeNewswire Inc. • 04/18/2024 12:00:00 PM
- 23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 • GlobeNewswire Inc. • 04/05/2024 08:05:00 PM
- 23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6 • GlobeNewswire Inc. • 03/20/2024 11:30:00 AM
- 23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago • GlobeNewswire Inc. • 03/19/2024 12:00:00 PM
- 23andMe Launches New Genetic Reports on Common Forms of Cancer • GlobeNewswire Inc. • 03/06/2024 12:30:00 PM
- 23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:36:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/07/2024 09:07:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 09:03:56 PM
- 23andMe Reports Third Quarter Fiscal 2024 Financial Results • GlobeNewswire Inc. • 02/07/2024 09:01:00 PM
- Moneta Gold and Nighthawk Gold Complete At-Market Merger to form STLLR Gold Inc. • Business Wire • 02/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 12:50:09 PM
- 23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernay • GlobeNewswire Inc. • 01/31/2024 03:12:36 AM
- Nighthawk Gold Obtains Final Court Order for the Proposed Arrangement • Business Wire • 01/30/2024 10:00:00 PM
- 23andMe to Report FY2024 Third Quarter Financial Results • GlobeNewswire Inc. • 01/24/2024 09:05:00 PM
- Moneta Gold and Nighthawk Gold Announce the Proposed Directors for the MergeCo Board • Business Wire • 01/22/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:45:21 PM
- 23andMe announces further expansion of 23ME-00610 Phase 1/2a clinical trial in advanced neuroendocrine and ovarian cancer patient cohorts • GlobeNewswire Inc. • 12/19/2023 01:00:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/01/2023 09:06:04 PM
- Nighthawk and Moneta Announce At-Market Merger to Create a Leading Canadian Gold Development Company • Business Wire • 11/28/2023 12:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 09:41:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 09:40:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:06:11 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM